<DOC>
	<DOC>NCT00546455</DOC>
	<brief_summary>Many metabolic complications of obesity are a consequence of abnormal responses of the liver, muscle, and fat to insulin actions. Fenretinide may improve the effects of insulin, preventing metabolic complications.</brief_summary>
	<brief_title>A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>BMI &gt;30 Diabetes Requiring Medication Poorly Controlled CoMorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>insulin resistance</keyword>
</DOC>